The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

NCT00518102 · clinicaltrials.gov ↗

COMPLETED

Status

4431

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: REGRANEX (becaplermin)
OTHER: REGRANEX (becaplermin) comparators

Sponsor

Ethicon, Inc.